Indole, indazole and indoline derivatives as CETP inhibitors

Details Indole, indazole and indoline derivatives as CETP inhibitors Indole, indazole and indoline derivatives as CETP inhibitors

2007-08-21

2007-08-21

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S405000, C548S361100, C548S490000

Reexamination Certificate

active

11197688

ABSTRACT:
The present invention relates to compounds of formula (I):wherein —X—Y—, R1to R11and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.

REFERENCES:
patent: 2003/0229120 (2003-12-01), Olsen et al.
patent: WO 2004/020393 (2004-03-01), None
patent: WO 2004/022523 (2004-03-01), None
Le Goff et al., Pharmacology & Therapeutics 101:17-38 (2004).
Okamoto et al., Nature 406:203-207 2000).
Archiv der Pharmazie, vol. 325, p. 433-437 (Jul. 1992).

Affiliated with

Also associated with

Rating

Indole, indazole and indoline derivatives as CETP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole, indazole and indoline derivatives as CETP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole, indazole and indoline derivatives as CETP inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3849900